Merck Manual

Please confirm that you are a health care professional

Loading

Klinefelter Syndrome (47,XXY)

(Klinefelter's Syndrome)

By

Nina N. Powell-Hamilton

, MD, Sidney Kimmel Medical College at Thomas Jefferson University

Last full review/revision Jun 2020| Content last modified Jun 2020
Click here for Patient Education
Topic Resources

Klinefelter syndrome is the presence of two or more X chromosomes plus one Y, resulting in a phenotypic male. Diagnosis is based on clinical findings and is confirmed by cytogenetic analysis. Treatment may include testosterone supplementation.

Klinefelter syndrome is the most common sex chromosome disorder, occurring in about 1/500 live male births. The extra X chromosomes are maternally derived in 60% of cases. Germ cells do not survive in the testes, leading to decreased sperm and androgens.

Affected boys tend to be tall with disproportionately long arms and legs. They often have small, firm testes, and about 30% develop gynecomastia.

Puberty usually occurs at the normal age, but often facial hair growth is light. There is a predisposition for verbal learning disorders. Clinical variation is great, and many 47,XXY males have normal appearance and intellect. Testicular development varies from hyalinized nonfunctional tubules to some production of spermatozoa; urinary excretion of follicle-stimulating hormone is frequently increased.

Mosaicism occurs in about 15% of cases. Males with a normal male karyotype (XY) in some cells may be fertile and have less obvious malformations. Some affected men have 3, 4, and even 5 X chromosomes along with the Y. As the number of X chromosomes increases, the severity of intellectual disability and of malformations also increases. Each extra X is associated with a 15- to 16-point reduction in IQ, with language most affected, particularly expressive language skills.

Diagnosis

  • Prenatal diagnosis often when cytogenetic testing is done for other reasons such as advanced maternal age

  • Detected postnatally on clinical appearance

  • Cytogenetic testing by karyotyping, fluorescent in situ hybridization (FISH) analysis, and/or chromosomal microarray analysis

The diagnosis of Klinefelter syndrome is suspected on physical examination of an adolescent with small testes and gynecomastia. Many men are diagnosed during an infertility evaluation (probably the majority of nonmosaic 47,XXY males are subfertile).

Diagnosis is confirmed by cytogenetic analysis (karyotyping, FISH analysis, and/or chromosomal microarray analysis). (See also diagnosis of chromosomal anomalies and Next-generation sequencing technologies.)

Treatment

  • Testosterone supplementation

  • Fertility preservation counseling just after onset of puberty

Males with Klinefelter syndrome should be evaluated by an endocrinologist to determine whether testosterone supplementation is indicated. Testosterone therapy is typically started at puberty to ensure the development of male sexual characteristics, muscle bulk, bone structure, and better psychosocial functioning. More recent studies have suggested that early hormone therapy may help with developmental and behavioral problems in boys with 47,XXY.

Boys with Klinefelter syndrome usually benefit from speech and language therapy and neuropsychologic testing for language comprehension, reading, and cognitive deficits.

After the onset of puberty, boys should receive counseling regarding fertility preservation.

Drugs Mentioned In This Article

Drug Name Select Trade
DELATESTRYL
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Overview of Tetralogy of Fallot
Video
Overview of Tetralogy of Fallot
3D Models
View All
Cystic Fibrosis: Defective Chloride Transport
3D Model
Cystic Fibrosis: Defective Chloride Transport

SOCIAL MEDIA

TOP